แปลง VitaStem VITASTEM เป็น Bitcoin BEP2 BTCB

VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.

Bitcoin BEP2 (BTCB) is a token that is pegged to BTC at a rate of 1 BTCB = 1 BTC, issued on the Binance Chain by Binance. Binance backs each BTCB token with equivalent amount of BTC in a reserve which can be validated with in the following address BTC Reserve Address: BTCB Issuance Address: The objective of issuing BTCB is to bring Bitcoin liquidity to the Binance Chain so users are able to trade Binance Chain issued tokens against Bitcoin, especially on the Binance DEX.